Amb motiu del tancament d'estiu, la validació de documents es reprendrà a partir del 28 d'agost de 2026. Disculpeu les molèsties.
Con motivo del cierre de verano, la validación de documentos se reanudará a partir del 28 de agosto de 2026. Disculpad las molestias
Due to the summer closure, document validation will resume starting August 28, 2026. We apologize for any inconvenience.

Document type

Article

Version

Published version

Publication date

Publication license

cc-by (c) Korrodi-Gregório, Luís et al., 2014
Please use this identifier to cite or link to this item: https://hdl.handle.net/2445/108406

TGF-β cascade regulation by PPP1 and its interactors -impact on prostate cancer development and therapy

Journal Title

Director/Tutor

Journal ISSN

Volume Title

Abstract

Protein phosphorylation is a key mechanism by which normal and cancer cells regulate their main transduction pathways. Protein kinases and phosphatases are precisely orchestrated to achieve the (de)phosphorylation of candidate proteins. Indeed, cellular health is dependent on the fine-tune of phosphorylation systems, which when deregulated lead to cancer. Transforming growth factor beta (TGF-β) pathway involvement in the genesis of prostate cancer has long been established. Many of its members were shown to be hypo- or hyperphosphorylated during the process of malignancy. A major phosphatase that is responsible for the vast majority of the serine/threonine dephosphorylation is the phospho-protein phosphatase 1 (PPP1). PPP1 has been associated with the dephospho-rylation of several proteins involved in the TGF-β cascade. This review will discuss the role of PPP1 in the regulation of several TGF-β signalling members and how the subversion of this pathway is related to prostate cancer development. Furthermore, current challenges on the protein phosphatases field as new targets to cancer therapy will be addressed.

Citation

Citation

KORRODI-GREGÓRIO, Luís, et al. TGF-β cascade regulation by PPP1 and its interactors -impact on prostate cancer development and therapy. Journal of Cellular and Molecular Medicine. 2014. Vol. 18, num. 4, pags. 555-567. ISSN 1582-1838. [consulted: 7 of August of 2026]. Available at: https://hdl.handle.net/2445/108406

Export metadata

JSON - METS

Share record